PROC
$4.33
Procaps Group S.A.
($.06)
(1.37%)
PROC
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  $0.06
Revenue:  N/A
Monday
Sep 4
5:30 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Monday, June 5, 2023

What do you expect when PROC reports earnings?
Beat
Meet
Miss

Where is PROC's stock price going from here?
Up
Flat
Down
Stock chart of PROC
Analysts
Summary of analysts' recommendations for PROC
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.